Skip to main content
. 2014 Jul-Aug;28(7):381–384. doi: 10.1155/2014/804969

TABLE 3.

Hepatitis C virus (HCV) antiviral recipient characteristics as a function of marijuana smoking status at the time of treatment initiation

Characteristic Current marijuana smoking
P
Yes (n=96) No (n=283)
Age, years 43.7±9.3 44.8±8.9 0.30
Weight, kg 77.5±18.8 79.3±18.3 0.40
HCV RNA, IU/mL 2.14±3.29×106 1.79±3.33×106 0.37
ALT, U/L 100±73 102±94 0.83
Male sex 77.1 70.7 0.23
Hepatitis C genotype 0.13
  1 67.7 60.8
  2 5.2 13.4
  3 26.0 20.8
  4 1.0 3.2
  5,6 0 1.8
Biopsy stage n=68 n=208 0.98
  0 4.4 5.2
  1 19.1 21.6
  2 44.1 41.8
  3 20.6 18.9
  4 11.8 12.5
HIV coinfection 0.73
  HIV positive 9.4 10.6
Race <0.01
  White 92.0 74.4
  Black 3.4 9.4
  Asian 0 13.3
  Aboriginal 4.6 3.0
Immigration status <0.001
  Immigrant 4.3 27.7
Injection drug history <0.001
  Yes 74.0 53.7
Alcohol use on treatment <0.01
  (>50 g/day) 17.7 6.7

Data presented as mean ± SD or % unless otherwise indicated. ALT Alanine aminotransferase